Loading clinical trials...
Loading clinical trials...
Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty - a Randomized, Two by Two Factorial, Double-blind, Placebo-controlled Clinical Trial
Conditions
Interventions
Epidiolex oral solution
Placebo
Locations
2
United States
University of Michigan
Ann Arbor, Michigan, United States
Henry Ford Health System
Detroit, Michigan, United States
Start Date
March 13, 2024
Primary Completion Date
January 1, 2029
Completion Date
January 1, 2029
Last Updated
April 15, 2026
NCT07548385
NCT05986292
NCT06929871
NCT07364578
NCT06488144
NCT07058623
Lead Sponsor
Chad Brummett
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions